Formulytica

Formulytica is an Australia-based specialty drug development organization focused on formulation development, analytical method development and validation, and technical transfer support for pharmaceutical and related health products. The company works primarily as a fee-for-service partner for clients developing topical, injectable, and oral products, with particular strength in dermatology and sterile injectable formulations. Formulytica also develops proprietary formulation and drug delivery technologies, including RNA-, peptide-, and ophthalmic-focused delivery approaches and a patented ocular anti-scarring platform developed with academic collaborators. Its capabilities span early development through support for preclinical and Phase 1/2 clinical programs, and the company has described itself in recent materials as a CDMO supporting early-stage topical and injectable drugs. The business appears to remain independently branded and operational in Melbourne, Australia.